日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept

经验教训:贝拉西普治疗钙调神经磷酸酶抑制剂和避免使用皮质类固醇的随机试验提前终止

Newell, K A; Mehta, A K; Larsen, C P; Stock, P G; Farris, A B; Mehta, S G; Ikle, D; Armstrong, B; Morrison, Y; Bridges, N; Robien, M; Mannon, R B

Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function

贝拉西普联合短暂性钙调神经磷酸酶抑制剂治疗可预防排斥反应并促进肾移植长期功能的改善。

Adams, A B; Goldstein, J; Garrett, C; Zhang, R; Patzer, R E; Newell, K A; Turgeon, N A; Chami, A S; Guasch, A; Kirk, A D; Pastan, S O; Pearson, T C; Larsen, C P

B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function

与耐受性相关的B细胞受体基因可识别出一组肾移植功能改善的免疫抑制患者。

Asare, A; Kanaparthi, S; Lim, N; Phippard, D; Vincenti, F; Friedewald, J; Pavlakis, M; Poggio, E; Heeger, P; Mannon, R; Burrell, B E; Morrison, Y; Bridges, N; Sanz, I; Chandraker, A; Newell, K A; Turka, L A

Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients

肾移植受者B细胞来源的耐受性特征的纵向研究

Newell, K A; Asare, A; Sanz, I; Wei, C; Rosenberg, A; Gao, Z; Kanaparthi, S; Asare, S; Lim, N; Stahly, M; Howell, M; Knechtle, S; Kirk, A; Marks, W H; Kawai, T; Spitzer, T; Tolkoff-Rubin, N; Sykes, M; Sachs, D H; Cosimi, A B; Burlingham, W J; Phippard, D; Turka, L A

Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study

干扰素γ ELISPOT检测作为肾移植损伤风险分层生物标志物:来自CTOT-01多中心研究的结果

Hricik, D E; Augustine, J; Nickerson, P; Formica, R N; Poggio, E D; Rush, D; Newell, K A; Goebel, J; Gibson, I W; Fairchild, R L; Spain, K; Iklé, D; Bridges, N D; Heeger, P S

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia

精神分裂症中N-甲基-D-天冬氨酸受体功能减退的分子证据

Weickert, C S; Fung, S J; Catts, V S; Schofield, P R; Allen, K M; Moore, L T; Newell, K A; Pellen, D; Huang, X-F; Catts, S V; Weickert, T W

Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.

多中心验证尿液 CXCL9 作为肾移植损伤风险分层生物标志物

Hricik D E, Nickerson P, Formica R N, Poggio E D, Rush D, Newell K A, Goebel J, Gibson I W, Fairchild R L, Riggs M, Spain K, Ikle D, Bridges N D, Heeger P S

Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients

供体特异性间接通路分析揭示了一种不依赖于B细胞的特征,该特征反映了肾移植受者的预后。

Haynes, L D; Jankowska-Gan, E; Sheka, A; Keller, M R; Hernandez-Fuentes, M P; Lechler, R I; Seyfert-Margolis, V; Turka, L A; Newell, K A; Burlingham, W J

Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice

小鼠多瘤病毒相关肾病是由适应性免疫而非病毒细胞病变介导的。

Albrecht, J A; Dong, Y; Wang, J; Breeden, C; Farris, A B 3rd; Lukacher, A E; Newell, K A

Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients

芝加哥大学原发性活体肝移植:前104例受者的技术方面

Millis, J M; Cronin, D C; Brady, L M; Newell, K A; Woodle, E S; Bruce, D S; Thistlethwaite, J R; Broelsch, C E